Paloma Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Paloma Partners’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,189	Closed	-$406K	–	2665
2019 Q3	$406K	Buy	+4,189	New	+$419K	0.01%	1321
2019 Q2	–	Sell	-29,529	Closed	-$3.36M	–	2356
2019 Q1	$3.36M	Buy	+29,529	New	+$2.17M	0.08%	272
2018 Q1	–	Sell	-4,642	Closed	-$239K	–	2394
2017 Q4	$239K	Buy	+4,642	New	+$333K	﹤0.01%	1643

Paloma Partners's ONCE Position: Q4 2019 in Review

Paloma Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 4,189 shares — an estimated $406K sold.

Paloma Partners first reported a position in ONCE in Q4 2017 and held it in 3 quarters. The position peaked at $3.36M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Paloma Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Paloma Partners sold 4,189 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $406K.
Paloma Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Paloma Partners's Spark Therapeutics, Inc. Common Stock position peaked at $3.36M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.